Standpoint Research Upgrades IBM (IBM) to Buy

Go back to Standpoint Research Upgrades IBM (IBM) to Buy

IBM (IBM) PT Lowered to $175 at Argus on 2Q Report; Revenue Slowdown in Strategic Initiatives Group Results in 21st Consecutive Quarter of Declining Revenues

July 21, 2017 7:55 AM EDT

Argus lowered its price target on IBM (NYSE: IBM) to $175.00 (from $192.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.

Analyst Jim Kelleher notes the company delivered second quarter earnings per share figures above consensus projections, but disappointed on revenues,... More